B

Bionano Genomics
D

BNGO

0.14220
USD
-0.04
(-23.38%)
Market Open
Volume
190,409
EPS
-0
Div Yield
-
P/E
-0
Market Cap
19,757,166
Related Instruments
    E
    EDIT
    -0.06000
    (-4.44%)
    1.29000 USD
    N
    NCSM
    -0.790
    (-2.58%)
    29.800 USD
    N
    NTRA
    -2.580
    (-1.50%)
    169.320 USD
    O
    OOMA
    0.030
    (0.21%)
    14.050 USD
    P
    PSTG
    -0.680
    (-0.94%)
    71.620 USD
    R
    RARE
    -0.050
    (-0.12%)
    42.900 USD
    R
    RGNX
    -0.36000
    (-4.59%)
    7.49000 USD
    V
    VEEV
    -10.670
    (-4.66%)
    218.440 USD
    More
News

Title: Bionano Genomics

Sector: Healthcare
Industry: Medical Instruments & Supplies
Bionano Genomics Inc is a life sciences instrumentation company in the genome analysis space. It is engaged in the development and marketing of the Saphyr system, a platform for ultra-sensitive and ultra-specific structural variation detection that enables researchers and clinicians to accelerate the search for new diagnostics and therapeutic targets and to streamline the study of changes in chromosomes. Geographically, it operates in Americas, EMEA and Asia Pacific; majority revenue being generated from Americas. They generate product revenue from sales of its OGM and Ionic Purification systems and consumables, which includes its instruments, and their VIA software.
Risk Disclosure: Trading in financial instruments involves high risks including the risk of losing some, or all, of your investment amount, and may not be suitable for all investors. Prices of cryptocurrencies are extremely volatile and may be affected by external factors such as financial, regulatory or political events. Trading on margin increases the financial risks. Before deciding to trade in financial instrument or cryptocurrencies you should be fully informed of the risks and costs associated with trading the financial markets, carefully consider your investment objectives, level of experience, and risk appetite, and seek professional advice where needed. Arincen would like to remind you that the data contained in this website is not necessarily real-time nor accurate. The data and prices on the website are not necessarily accurate and may differ from the actual price at any given market, meaning prices are indicative and not appropriate for trading purposes. Arincen and any provider of the data contained in this website will not accept liability for any loss or damage as a result of your trading, or your reliance on the information contained within this website. It is prohibited to use, store, reproduce, display, modify, transmit or distribute the data contained in this website without the explicit prior written permission of Arincen and/or the data provider. All intellectual property rights are reserved by the providers and/or the exchange providing the data contained in this website. Arincen may be compensated by the advertisers that appear on the website, based on your interaction with the advertisements or advertisers.